Matthew M. Walsh - Mar 31, 2024 Form 4 Insider Report for Organon & Co. (OGN)

Role
Chief Financial Officer
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Matthew M. Walsh
Stock symbol
OGN
Transactions as of
Mar 31, 2024
Transactions value $
-$183,338
Form type
4
Date filed
4/3/2024, 06:42 PM
Previous filing
Apr 2, 2024
Next filing
May 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +7.75K +10.47% $0.00 81.8K Mar 31, 2024 Direct
transaction OGN Common Stock Tax liability -$71.8K -3.82K -4.67% $18.80 78K Mar 31, 2024 Direct
transaction OGN Common Stock Options Exercise $0 +12K +15.44% $0.00 90K Mar 31, 2024 Direct
transaction OGN Common Stock Tax liability -$112K -5.93K -6.59% $18.80 84.1K Mar 31, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -7.75K -50% $0.00 7.75K Mar 31, 2024 Common Stock 7.75K Direct F1, F2
transaction OGN Restricted Stock Units Options Exercise $0 -12K -33.33% $0.00 24.1K Mar 31, 2024 Common Stock 12K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock.
F2 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025.
F3 On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026.